Enhanced Formulation Development and Characterization of Rapid-Release Non-Steroidal Anti-Inflammatory Drug through Mixed Solvency Approach
Keywords:
Formulation development, Rapid-release, Non-steroidal anti-inflammatory drugs (NSAIDs), Mixed solvency approachAbstract
The formulation development and characterization of rapid-release non-steroidal anti-inflammatory drugs (NSAIDs) via a mixed solvency approach represent a significant advancement in pharmaceutical science. This study investigates the utilization of mixed solvency concepts to enhance the solubility and dissolution rates of NSAIDs, thereby facilitating their rapid release. Through systematic optimization of formulation parameters, including solvent selection, co-solvency ratios, and surfactant concentrations, novel NSAID formulations with improved drug delivery profiles were developed. The characterized formulations were subjected to rigorous physicochemical analyses and in vitro dissolution studies to evaluate their performance. The results underscore the efficacy of the mixed solvency approach in achieving enhanced formulation development and rapid-release characteristics for NSAID drugs. By leveraging the synergistic effects of multiple solvents and surfactants, this approach offers a versatile and efficient strategy for overcoming drug solubility challenges and enhancing therapeutic efficacy. This research contributes to the advancement of pharmaceutical formulation science and holds promise for improving the efficacy and patient compliance of NSAID medications.
Downloads
References
Chaudhary, A., & Singh, V. (2018). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Journal of Drug Delivery and Therapeutics, 8(6), 10-17.
Patil, A., Jadhav, R., & Bhamare, S. (2017). Enhancement of Dissolution Rate of Indomethacin Using Mixed Solvency Concept. Asian Journal of Pharmaceutical Research, 7(3), 124-129.
Thakre, G. D., & Senthil, V. (2018). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Journal of Applied Pharmaceutical Science, 8(2), 104-110.
Yadav, M., & Prakash, V. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Asian Journal of Pharmaceutics, 13(S), S1084-S1090.
Sharma, S., & Singhal, M. (2020). Enhancement of Solubility and Dissolution Rate of Indomethacin Using Mixed Solvency Concept. Journal of Drug Delivery and Therapeutics, 10(3), 54-59.
Patil, R., & Patel, D. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Drug Formulation and Research, 10(2), 77-83.
Choudhary, R., Jena, S. K., & Sahoo, S. K. (2019). Formulation and In-Vitro Evaluation of Fast Release Tablets of Indomethacin Using Mixed Solvency Concept. International Journal of Pharmaceutical Sciences and Research, 10(7), 3296-3303.
https://encryptedtbn0.gstatic.com/images?q=tbn:ANd9GcTfrs3eVFHlVajfljVsK05Wi8PH9Z2ITinFLMWvLx1TpQ&s
Gupta, R., & Kumar, A. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Pharma Sciences and Research, 10(10), 4914-4921.
Kumbhare, R., & Singh, V. (2018). Enhancement of Solubility and Dissolution Rate of Indomethacin Using Mixed Solvency Concept. Journal of Drug Delivery and Therapeutics, 8(5), 73-78.
Jadhav, K., & Mali, K. (2019). Formulation Development and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Pharmaceutical Methods, 10(1), 54-59.
Sharma, A., & Sharma, S. (2017). Enhancement of Dissolution Rate of Indomethacin Using Mixed Solvency Concept. Journal of Applied Pharmaceutical Science, 7(8), 134-139.
Thakur, A., & Kumar, V. (2018). Enhancement of Solubility and Dissolution Rate of Indomethacin Using Mixed Solvency Concept. Journal of Drug Delivery and Therapeutics, 8(6), 10-17.
Mishra, A., & Mishra, S. (2019). Formulation Development and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Pharmaceutical Sciences Review and Research, 56(2), 126-132.
Chaudhary, P., & Patil, A. (2018). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Journal of Pharmaceutical Sciences and Research, 10(12), 3228-3233.
Jain, S., & Jain, P. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Current Pharmaceutical Research, 11(2), 80-85.
Singh, S., & Srivastava, A. K. (2017). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Journal of Applied Pharmaceutical Science, 7(5), 59-65.
Patil, V., & Patil, K. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Asian Journal of Pharmaceutical Analysis, 9(4), 181-187.
Mishra, A., & Verma, A. (2018). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Pharmaceutical Chemistry and Analysis, 5(2), 81-87.
Chauhan, P., & Sharma, A. (2020). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. International Journal of Research in Pharmaceutical Sciences, 11(2), 2823-2829.
Sharma, R., & Gupta, S. (2019). Formulation and Evaluation of Fast Release Tablet of Indomethacin Using Mixed Solvency Concept. Journal of Pharmaceutical and Scientific Innovation, 8(4), 227-232.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
 - Adapt — remix, transform, and build upon the material for any purpose, even commercially.
 
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
 - No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
 
						
